BMY

3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA)

Mylan (MYL) is bouncing back to life on an Epipen settlement, Bristol-Myers Squibb (BMY) is getting hit again on Opdivo disappointment and everyone still hates Comcast (CMCSA). More 

6 Pharmaceuticals Stocks to Sell Now

The ratings of 6 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

This Well-Known Dividend Giant Is On Sale (BMY)

If a Blue Chip stock drops 16% in one day, do you rush to buy? In the case of Bristol-Meyers, the answer is yes. Time to consider BMY stock More 

Bristol-Myers Squibb Co: The BMY Freefall Is Overdone

BMY stock has sustained a technical beatdown over the past couple of days. But Bristol-Myers Squibb is arriving at promising support. More 

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today. More 

BMY Stock: It’s Time to Buy Bristol-Myers Squibb Co

Following a failed cancer drug approval, BMY stock dropped nearly 16%. That appears to be an overreaction, so time to take a bullish stance. More